JFL Life Sciences
JFLLIFE · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 14, 2025

Stock Price vs Company Growth
1d
0.0%
1w
14.0%
1m
31.1%
3m
25.5%
6m
17.4%
all
12.9%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 11.8 0%
8.7
11.9
Company Overview

Sales
131 Cr
Growth: 9.6%
Profit after Tax
6.4 Cr
Growth: 32.7%
Micro Cap
38.9 Cr
P/E: 6.1x
Industry P/E: 32.8x
Fundamentals

Sales (Cr) ₹ 131
Growth 9.6%
EBITDA 8.9%
P/S 0.3x
Dividend 0.0%
P/E 6.1x
Book Value ₹ 13.9
PEG Ratio 0.6x
ROE 14.8%
P/B 0.8x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

JFL Life Sciences manufactures a wide range of pharmaceutical formulations. The company’s major products types are Dry powder injections; Tablets & Capsules (B-Lactam) solid oral dosage form; Tablet and capsules (General); and Oral Rehydration Solutions (ORS). Major Events and Milestones2010: The company was incorporated as a private limited company under the name JFL Life Sciences Private Limited.
Belongs to (1 Indices)